HAN-GINS Tech Megatrend UCITS ETF – ITEK
Synopsis of Tech Megatrend ETF
HAN-GINS Global Tech Megatrend UCITS ETF, is a UCITS compliant Exchange Traded Fund domiciled in Ireland.The fund tracks the Solactive Innovative Technologies Index.
The fund seeks to provide exposure to “Industry 4.0” – the companies poised to benefit from the fourth industrial revolution – including those involved in Robotics & Automation, Cloud Computing & Big Data, Cyber Security, Future Cars, Genomics, Social Media, Blockchain and Augmented & Virtual Reality.
Please remember that the value of your investment may go down as well as up and past performance is no indication of future performance.
.
Tech Megatrend ETF (ITEK) Fact Sheets
Tech Megatrend (ITEK) Market Monthly Report
Global Trends
ITEK constituents are not limited to one region or country, providing exposure to innovative companies on a global basis.
Transparent, Modern Approach
ITEK follows a transparent rules-based index to identify and capture companies that are leading technology innovation.
Efficient
In a single trade, ITEK delivers exposure to a diversified basket of companies with high exposure to the innovative technology theme.
Diversification
ITEK avoids concentration in larger stocks by using a double diversification approach that allocates an equal weight to each innovative theme and then equal weights constituents within that theme.
| Ticker | ITEK |
| Asset Class | Equities |
| ISIN | IE00BDDRF700 |
| TER | 0.59% |
| Custody Fee | 0.25% (if traded via GinsGlobal) |
| Inception Date | 05/10/2018 |
| Index | Solactive Innovative Technologies Index (Net Total Return) |
| Domicile | Ireland |
| Fund Reporting Status | Yes |
| Legal Entity | UCITS |
| Listings | BI, CBOE, ISE, LSE, Xetra |
Learn more about this fund at hanetf
Contact
Please approach your intermediary or contact us directly on:
ag@ginsglobal.com
USA (310) 432-4374 / (310) 801 4974 or
SA +27(0)11 8839862 / +27(0)828964234
Index Funds - Did You Know
Index funds outperform more than 80% of active fund managers over 3 - 15 years.